Pharma Horizons: Environmental Monitoring
By European Pharmaceutical Review
FDA approval could shape liver disease treatment landscape
By Catherine Eckford (European Pharmaceutical Review)
Developing a new treatment paradigm for IgAN
By Catherine Eckford (European Pharmaceutical Review), Dr Marshall Fordyce (Vera…
Boehringer collaboration could advance first-in-class schizophrenia treatments
By Catherine Eckford (European Pharmaceutical Review)
Validation of analytical procedures – ICH Q2(R2)
By Dave Elder (JPAG Member and David P Elder Consultancy)
Developing a new treatment paradigm for IgAN
By Catherine Eckford (European Pharmaceutical Review), Dr Marshall Fordyce (Vera…